Latest

Pigment Epithelial Detachment Market Expected to Experience Substantial Expansion Across 7MM, Propelled by Growing Elderly Demographics and Cutting-Edge Treatments | DelveInsight

25 March 2026
The pigment epithelial detachment (PED) market is set for remarkable expansion, underpinned by multiple contributing factors such as a rising geriatric population, breakthroughs in artificial intelligence-based diagnostic tools, strategic industry partnerships, and the introduction of next-generation treatment modalities. Leading companies operating in

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

25 March 2026
According to DelveInsight’s latest evaluation, the global Tourette syndrome treatment pipeline features more than 6 prominent companies actively advancing over 6 investigational therapies. The comprehensive assessment covers ongoing clinical trials, therapeutic candidates, mechanisms of action, administration routes, and notable developmental milestones. The
1 13 14 15 16 17 31